Filters

Prescrire international

Showing results (781-790 of 1,424) with videos related to

Pageof 143
Sort By:
Prescrire International|July 17, 2008
Idursulfase: a poor risk-benefit balance in type II mucopolysaccharidosis
Prescrire International|July 18, 2008
Arterial hypertension: second-line treatment. Try other single-agent treatments
Prescrire International|July 18, 2008
Herbal remedies for dyspepsia: peppermint seems effective
Prescrire International|July 30, 2009
Etravirine: new drug. Multidrug-resistant HIV: another option
Prescrire International|July 30, 2009
Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes
Prescrire International|July 30, 2009
Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors
Prescrire International|July 30, 2009
Mecasermin: new drug. Insufficient improvement in statural growth
Prescrire International|July 30, 2009
Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity
Prescrire International|July 30, 2009
Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests
Prescrire International|May 12, 2010
Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate
Pageof 143

Showing results (781-790 of 1,424) with videos related to

Sort By:
Pageof 143
Prescrire International|July 17, 2008
Idursulfase: a poor risk-benefit balance in type II mucopolysaccharidosis
Prescrire International|July 18, 2008
Arterial hypertension: second-line treatment. Try other single-agent treatments
Prescrire International|July 18, 2008
Herbal remedies for dyspepsia: peppermint seems effective
Prescrire International|July 30, 2009
Etravirine: new drug. Multidrug-resistant HIV: another option
Prescrire International|July 30, 2009
Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes
Prescrire International|July 30, 2009
Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors
Prescrire International|July 30, 2009
Mecasermin: new drug. Insufficient improvement in statural growth
Prescrire International|July 30, 2009
Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity
Prescrire International|July 30, 2009
Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests
Prescrire International|May 12, 2010
Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate
Pageof 143
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us